Literature DB >> 8445434

Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.

R D Gelber1, A Goldhirsch, A S Coates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8445434     DOI： 10.1200/JCO.1993.11.3.580

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors.

Authors:  Panos Savvides; Norma Terrin; John Erban; Harry P Selker
Journal:  Support Care Cancer       Date:  2003-03-11       Impact factor: 3.603

2.  The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer.

Authors:  M Dowsett; J S Tobias; A Howell; G M Blackman; H Welch; N King; R Ponzone; M von Euler; M Baum
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

3.  Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant).

Authors:  M Singhal; T P Sahoo; S Aggarwal; A Singhvi; V Kaushal; S Rajpurohit; K M Parthasarthi; A Vora; M Ganvir; S Gupta; Purvish M Parikh
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.